SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

HANSA BIOPHARMA AB - Q3 REVENUE TOTALS SEK 143.0 MLN COMPARED TO SEK 30.8 MLN IN Q3 2025

Related stories